5l9d - Revision history

OCA at 16:12, 4 October 2023

OCA — Wed, 04 Oct 2023 16:12:06 GMT

←Older revision		Revision as of 16:12, 4 October 2023
Line 3:		Line 3:
	<StructureSection load='5l9d' size='340' side='right'caption='[[5l9d]], [[Resolution\|resolution]] 1.88Å' scene=''>		<StructureSection load='5l9d' size='340' side='right'caption='[[5l9d]], [[Resolution\|resolution]] 1.88Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://proteopedia.org/fgij/fg.htm?mol=5L9D FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5L9D FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene>~~</td></tr>~~	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.88Å</td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5l7x\|5l7x]], [[5lgh\|5lgh]]~~</td></tr>	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://proteopedia.org/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [~~http~~://pdbe.org/5l9d PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [https://pdbe.org/5l9d PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [https://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 28:		Line 28:
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
-	[[Category: Naschberger, A]]	+	[[Category: Naschberger A]]
-	[[Category: Rupp, B]]	+	[[Category: Rupp B]]
-	~~[[Category: Afamin antibody]]~~	+
-	~~[[Category: Fab fragment]]~~	+
-	~~[[Category: Igg1-kappa]]~~	+
-	~~[[Category: Immune system]]~~	+
-	~~[[Category: Light chain glycosilation~~]]	+

OCA at 07:03, 5 August 2020

OCA — Wed, 05 Aug 2020 07:03:03 GMT

←Older revision		Revision as of 07:03, 5 August 2020
Line 1:		Line 1:

	==AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM I, parsimonious model==		==AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM I, parsimonious model==
-	<StructureSection load='5l9d' size='340' side='right' caption='[[5l9d]], [[Resolution\|resolution]] 1.88Å' scene=''>	+	<StructureSection load='5l9d' size='340' side='right'caption='[[5l9d]], [[Resolution\|resolution]] 1.88Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5L9D FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5L9D FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5l7x\|5l7x]], [[5lgh\|5lgh]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5l7x\|5l7x]], [[5lgh\|5lgh]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 17:		Line 17:
	</div>		</div>
	<div class="pdbe-citations 5l9d" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 5l9d" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Antibody 3D structures\|Antibody 3D structures]]
		+	*[[Sandbox 20009\|Sandbox 20009]]
		+	*[[3D structures of non-human antibody\|3D structures of non-human antibody]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Large Structures]]
	[[Category: Mus musculus]]		[[Category: Mus musculus]]
	[[Category: Naschberger, A]]		[[Category: Naschberger, A]]

OCA at 10:06, 22 November 2017

OCA — Wed, 22 Nov 2017 10:06:00 GMT

←Older revision		Revision as of 10:06, 22 November 2017
Line 5:		Line 5:
	<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L9D FirstGlance]. <br>		<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L9D FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>
-	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5lgh\|5lgh]]</td></tr>	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5l7x\|5l7x]], [[5lgh\|5lgh]]</td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>
	</table>		</table>

OCA at 14:15, 22 December 2016

OCA — Thu, 22 Dec 2016 14:15:15 GMT

←Older revision		Revision as of 14:15, 22 December 2016
Line 8:		Line 8:
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>
	</table>		</table>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	The monoclonal antibody N14 is used as a detection antibody in ELISA kits for the human glycoprotein afamin, a member of the albumin family, which has recently gained interest in the capture and stabilization of Wnt signalling proteins, and for its role in metabolic syndrome and papillary thyroid carcinoma. As a rare occurrence, the N14 Fab is N-glycosylated at Asn26L at the onset of the VL1 antigen-binding loop, with the alpha-1-6 core fucosylated complex glycan facing out of the L1 complementarity-determining region. The crystal structures of two non-apparent (pseudo) isomorphous crystals of the N14 Fab were analyzed, which differ significantly in the elbow angles, thereby cautioning against the overinterpretation of domain movements upon antigen binding. In addition, the map quality at 1.9 A resolution was sufficient to crystallographically re-sequence the variable VL and VH domains and to detect discrepancies in the hybridoma-derived sequence. Finally, a conservatively refined parsimonious model is presented and its statistics are compared with those from a less conservatively built model that has been modelled more enthusiastically. Improvements to the PDB validation reports affecting ligands, clashscore and buried surface calculations are suggested.
		+
		+	The N14 anti-afamin antibody Fab: a rare VL1 CDR glycosylation, crystallographic re-sequencing, molecular plasticity and conservative versus enthusiastic modelling.,Naschberger A, Furnrohr BG, Lenac Rovis T, Malic S, Scheffzek K, Dieplinger H, Rupp B Acta Crystallogr D Struct Biol. 2016 Dec 1;72(Pt 12):1267-1280. Epub 2016 Nov 29. PMID:27917827<ref>PMID:27917827</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 5l9d" style="background-color:#fffaf0;"></div>
		+	== References ==
		+	<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>

OCA at 04:21, 4 August 2016

OCA — Thu, 04 Aug 2016 04:21:59 GMT

←Older revision		Revision as of 04:21, 4 August 2016
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry 5l9d is ON HOLD until Paper Publication~~	+	==AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1- GLYCOSYLATED, CRYSTAL FORM I, parsimonious model==
-		+	<StructureSection load='5l9d' size='340' side='right' caption='[[5l9d]], [[Resolution\|resolution]] 1.88Å' scene=''>
-	~~Authors: Rupp, B., Naschberger, A.~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[5l9d]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5L9D OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5L9D FirstGlance]. <br>
-	~~Description:~~ AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1-GLYCOSYLATED, CRYSTAL FORM I, parsimonious model	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=K:POTASSIUM+ION'>K</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PE8:3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL'>PE8</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene>, <scene name='pdbligand=PGE:TRIETHYLENE+GLYCOL'>PGE</scene></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[5lgh\|5lgh]]</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5l9d FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5l9d OCA], [http://pdbe.org/5l9d PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5l9d RCSB], [http://www.ebi.ac.uk/pdbsum/5l9d PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5l9d ProSAT]</span></td></tr>
		+	</table>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Mus musculus]]
	[[Category: Naschberger, A]]		[[Category: Naschberger, A]]
	[[Category: Rupp, B]]		[[Category: Rupp, B]]
		+	[[Category: Afamin antibody]]
		+	[[Category: Fab fragment]]
		+	[[Category: Igg1-kappa]]
		+	[[Category: Immune system]]
		+	[[Category: Light chain glycosilation]]

OCA at 09:50, 14 July 2016

OCA — Thu, 14 Jul 2016 09:50:46 GMT

←Older revision		Revision as of 09:50, 14 July 2016
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 5l9d is ON HOLD	+	The entry 5l9d is ON HOLD until Paper Publication

	Authors: Rupp, B., Naschberger, A.		Authors: Rupp, B., Naschberger, A.

-	Description: AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1-~~GLYCOSILATED~~, CRYSTAL FORM I, parsimonious model	+	Description: AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1-GLYCOSYLATED, CRYSTAL FORM I, parsimonious model
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
	[[Category: Naschberger, A]]		[[Category: Naschberger, A]]
	[[Category: Rupp, B]]		[[Category: Rupp, B]]

OCA: Protected "5l9d" [edit=sysop:move=sysop]

OCA — Thu, 23 Jun 2016 21:52:52 GMT

Protected "5l9d" [edit=sysop:move=sysop]

←Older revision

Revision as of 21:52, 23 June 2016

OCA: New page: '''Unreleased structure''' The entry 5l9d is ON HOLD Authors: Rupp, B., Naschberger, A. Description: AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1-GLYCOSILATED, CRYSTAL FORM I, parsimonious mo...

OCA — Thu, 23 Jun 2016 21:52:50 GMT

New page: '''Unreleased structure''' The entry 5l9d is ON HOLD Authors: Rupp, B., Naschberger, A. Description: AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1-GLYCOSILATED, CRYSTAL FORM I, parsimonious mo...

New page

'''Unreleased structure'''

The entry 5l9d is ON HOLD

Authors: Rupp, B., Naschberger, A.

Description: AFAMIN ANTIBODY FRAGMENT, N14 FAB, L1-GLYCOSILATED, CRYSTAL FORM I, parsimonious model
[[Category: Unreleased Structures]]
[[Category: Naschberger, A]]
[[Category: Rupp, B]]